Chinese General Practice ›› 2020, Vol. 23 ›› Issue (12): 1559-1565.DOI: 10.12114/j.issn.1007-9572.2019.00.819
Special Issue: 心血管最新文章合辑
• Monographic Research • Previous Articles Next Articles
Published:
2020-04-20
Online:
2020-04-20
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2019.00.819
[1]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要[J].中国循环杂志,2018,33(1):1-8.DOI:10.3969/j.issn.1000-3614.2018.01.001. CHEN W W,GAO R L,LIU L S,et al.China cardiovascular disease report 2017 summary[J]. China Circulation Magazine,2018,33(1):1-8. DOI:10.3969/j.issn.1000-3614.2018.01.001. [2]AFARI M E,BHAT T.Neutrophil to lymphocyte ratio(NLR) and cardiovascular diseases:an update[J].Expert Rev Cardiovasc Ther,2016,14(5):573-577.DOI:10.1586/14779072.2016.1154788. [3]牛镜磊,张钲.新型炎性标志物在动脉粥样硬化中的研究进展[J].中国循环杂志,2017,32(5):516-517.DOI:10.3969/j.issn.1000-3614.2017.05.022. NIU J L,ZHANG Z.Research progress of new inflammatory markers in atherosclerosis[J].China Circulation Magazine,2017,32(5):516-517.DOI:10.3969/j.issn.1000-3614.2017.05.022. [4]BHAT T,TELI S,RIJAL J,et al.Neutrophil to lymphocyte ratio and cardiovascular diseases:a review[J].Expert Rev Cardiovasc Ther,2013,11(1):55-59.DOI:10.1586/erc.12.159. [5]BUDZIANOWSKI J,PIESZKO K,BURCHARDT P,et al.The role of hematological indices in patients with acute coronary syndrome[J].Dis Markers,2017,2017:3041565.DOI:10.1155/2017/3041565. [6]SHEN X H,CHEN Q,SHI Y,et al.Association of neutrophil/lymphocyte ratio with long-term mortality after ST elevation myocardial infarction treated with primary percutaneous coronary intervention[J].Chin Med J,2010,123(23):3438-3443.DOI:10.3760/cma.j.issn.0366—6999.2010.23.012. [7]SAWANT A C,ADHIKARI P,NARRA S R,et al.Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction[J].Cardiol J,2014,21(5):500-508.DOI:10.5603/CJ.a2013.0148. [8]ONSRUD M,THORSBY E.Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations.I.Effect on natural killer cell activity[J].Scand J Immunol,1981,13(6):573-579.DOI:10.1111/j.1365-3083.1981.tb00171.x. [9]董文超,王瑞鹃,严亚琪,等.中性粒细胞/淋巴细胞比值与冠心病及Gensini评分的相关性研究[J].河北医学,2018,24(6):997-1000.DOI:10.3969 /j.issn.1006-6233.2018.06.031. DONG W C,WANG R J,YAN Y Q,et al.Study on the relationship among neutrophil lymphocyte ratio,coronary artery disease and gensini score[J].Hebei Med,2018,24(6):997-1000.DOI:10.3969 /j.issn.1006-6233.2018.06.031. [10]ZHANG G Y,CHEN M,YU Z M,et al.Relation between neutrophil-to-lymphocyte ratio and severity of coronary artery stenosis[J].Genet Mol Res,2014,13(4):9382-9389.DOI:10.4238/2014.November.11.4. [11]BAJARI R,TAK S.Predictive prognostic value of neutrophil-lymphocytes ratio in acute coronary syndrome[J].Indian Heart J,2017,69(Suppl 1):S46-50.DOI:10.1016/j.ihj.2017.01.020. [12]刘子铭,赵菲菲,李凯勇,等.中性粒细胞与淋巴细胞比值和冠心病关系的探讨[J].武汉大学学报:医学版,2018,39(1):114-119.DOI:10.14188/j.1671-8852.2017.0037. LIU Z M,ZHAO F F,LI K Y,et al.Relationship between neutrophil-to-lymphocyte ratio and coronary artery disease[J].Medical Journal of Wuhan University,2018,39(1):114-119.DOI:10.14188/j.1671-8852.2017.0037. [13]NALBANT A,CINEMRE H,KAYA T,et al.Neutrophil to lymphocyte ratio might help prediction of acute myocardial infarction in patients with elevated serum creatinine[J].Pak J Med Sci,2016,32(1):106-110.DOI:10.12669/pjms.321.8712. [14]NEWBY L K,JESSE R L,BABB J D,et al.ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations:a report of the American college of cardiology foundation task force on clinical expert consensus documents[J].J Am Coll Cardiol,2012,60(23):2427-2463.DOI:10.1016/j.jacc.2012.08.969. [15]CHEN C,CONG B L,WANG M,et al.Neutrophil to lymphocyte ratio as a predictor of myocardial damage and cardiac dysfunction in acute coronary syndrome patients[J].Integr Med Res,2018,7(2):192-199.DOI:10.1016/j.imr.2018.02.006. [16]DINIZ L R,DE LIMA S G,DE AMORIM GARCIA J M,et al.Neutrophil to lymphocyte ratio as a prognostic predictor in older people with acute coronary syndrome[J].Angiology,2018:3319718796565.DOI:10.1177/0003319718796565. [17]LAMAS G A,FLAKER G C,MITCHELL G,et al.Effect of infarct artery patency on prognosis after acute myocardial infarction.The Survival and Ventricular Enlargement Investigators[J].Circulation,1995,92(5):1101-1109.DOI:10.1161/01.CIR.92.5.11 01. [18]DOGAN M,AKYEL A,BILGIN M,et al.Can admission neutrophil to lymphocyte ratio predict infarct-related artery patency in ST-segment elevation myocardial infarction[J].Clin Appl Thromb Hemost,2015,21(2):172-176.DOI:10.1177/1076029613515071. [19]UYSAL O K,TURKOGLU C,SAHIN D Y,et al.The relationship between neutrophil-to-lymphocyte ratio and coronary collateral circulation[J].Clin Appl Thromb Hemost,2015,21(4):329-333.DOI:10.1177/1076029613503399. [20]AKIN F,AYCA B,CELIK O,et al.Predictors of poor coronary collateral development in patients with stable coronary artery disease:neutrophil-to-lymphocyte ratio and platelets[J].Anatol J Cardiol,2015,15(3):218-223.DOI:10.5152/akd.2014.5263. [21]DONG C H,WANG Z M,CHEN S Y.Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome:a systematic review and meta-analysis[J].Clin Biochem,2018,52:131-136.DOI:10.1016/j.clinbiochem.2017.11.008. [22]ZHANG S,DIAO J,QI C M,et al.Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention:a meta-analysis[J].BMC Cardiovasc Disord,2018,18(1):75.DOI:10.1186/s12872-018-0812-6. [23]XU N,TANG X F,YAO Y,et al.Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction[J].Catheter Cardiovasc Interv,2018,91(S1):551-557.DOI:10.1002/ccd.27495. [24]WADA H,DOHI T,MIYAUCHI K,et al.Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease[J].Atherosclerosis,2017,265:35-40.DOI:10.1016/j.atherosclerosis.2017.08.007. [25]GABBASOV Z,KOZLOV S,MELNIKOV I,et al.Novel biomarkers for coronary restenosis occurrence after drug-eluting stent implantation in patients with diabetes having stable coronary artery disease[J].Clin Appl Thromb Hemost,2018,24(8):1308-1314.DOI:10.1177/1076029618771752. [26]TANINDI A,EKICI B,TORE H F.Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?[J].Turk Kardiyol Dern Ars,2015,43(5):457-464.DOI:10.5543/tkda.2015.48275. [27]MACHADO G P,ARAUJO G N,CARPES C K,et al.Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction[J].Atherosclerosis,2018,274:212-217.DOI:10.1016/j.atherosclerosis.2018.05.022. [28]KURTUL A,YARLIOGLUES M,DURAN M,et al.Association of neutrophil-to-lymphocyte ratio with contrast-induced nephropathy in patients with non-ST-elevation acute coronary syndrome treated with percutaneous coronary intervention[J].Heart Lung Circ,2016,25(7):683-690.DOI:10.1016/j.hlc.2016.01.007. [29]WEYMANN A,ALI HASAN AL SAEGH S,POPOV A F,et al.Haematological indices as predictors of atrial fibrillation following isolated coronary artery bypass grafting,valvular surgery,or combined procedures:a systematic review with meta-analysis[J].Kardiol Pol,2018,76(1):107-118.DOI:10.5603/KP.a2017.0179. [30]陈灏珠.内科学[M].9版.北京:人民卫生出版社,2018:166-285. [31]PRABHU S D.Cytokine-induced modulation of cardiac function[J].Circ Res,2004,95(12):1140-1153.DOI:10.1161/01.RES.0000150734.79804.92. [32]UTHAMALINGAM S,PATVARDHAN E A,SUBRAMANIAN S,et al.Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure[J].Am J Cardiol,2011,107(3):433-438.DOI:10.1016/j.amjcard.2010.09.039. [33]DURMUS E,KIVRAK T,GERIN F,et al.Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are predictors of heart failure[J].Arq Bras Cardiol,2015,105(6):606-613.DOI:10.5935/abc.20150126. [34]陈小东.中性粒细胞与淋巴细胞比值与慢性心力衰竭患者血清NT-proBNP的相关性分析[J].健康研究,2016,36(3):276-278.DOI:10.3969/j.issn.1674_6449.2016.03.013. CHEN X D.Correlation analysis between neutrophil and lymphocyte ratio and serum NT-proBNP in patients with chronic heart failure[J].Health Research,2016,36(3):276-278.DOI:10.3969/j.issn.1674_6449.2016.03.013. [35]NEWBY L K,JESSE R L,BABB J D,et al.ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations:a report of the American college of cardiology foundation task force on clinical expert consensus documents[J].J Am Coll Cardiol,2012,60(23):2427-2463.DOI:10.1016/j.jacc.2012.08.969. [36]BALCI K G,BALCI M M,SEN F,et al.The role of baseline indirect inflammatory markers in prediction of response to cardiac resynchronisation therapy[J].Kardiol Pol,2016,74(2):119-126.DOI:10.5603/KP.a2015.0142. [37]YOST G L,JOSEPH C R,TATOOLES A J,et al.Neutrophil-to-lymphocyte ratio predicts outcomes in patients implanted with left ventricular assist devices[J].ASAIO J,2015,61(6):664-669.DOI:10.1097/MAT.0000000000000267. [38]BENITES-ZAPATA V A,HERNANDEZ A V,NAGARAJAN V,et al.Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure[J].Am J Cardiol,2015,115(1):57-61.DOI:10.1016/j.amjcard.2014.10.008. [39]SEROPIAN I M,ROMEO F J,PIZARRO R,et al.Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of survival after heart transplantation[J].ESC Heart Fail,2018,5(1):149-156.DOI:10.1002/ehf2.12199. [40]WAN G X,JI L H,XIA W B,et al.Screening genes associated with elevated neutrophil?to?lymphocyte ratio in chronic heart failure[J].Mol Med Rep,2018,18(2):1415-1422.DOI:10.3892/mmr.2018.9132. [41]BELEN E,SUNGUR A,SUNGUR M A,et al.Increased neutrophil to lymphocyte ratio in patients with resistant hypertension[J].J Clin Hypertens(Greenwich),2015,17(7):532-537.DOI:10.1111/jch.12533. [42]YAYLA ?,CANPOLAT U,AKYEL A,et al.Association of neutrophil-lymphocyte ratio with impaired aortic elasticity in newly diagnosed and never-treated hypertensive patients[J].Blood Press Monit,2015,20(3):127-131.DOI:10.1097/MBP.0000000000000104. [43]LIU X,ZHANG Q,WU H M,et al.Blood neutrophil to lymphocyte ratio as a predictor of hypertension[J].Am J Hypertens,2015,28(11):1339-1346.DOI:10.1093/ajh/hpv034. [44]?IMEN T,SUNMAN H,EFE T H,et al.The relationship between 24-hour ambulatory blood pressure load and neutrophil-to-lymphocyte ratio[J].Rev Port Cardiol,2017,36(2):97-105.DOI:10.1016/j.repc.2016.07.009. [45]KILICASLAN B,DURSUN H,KAYMAK S,et al.The relationship between neutrophil to lymphocyte ratio and blood pressure variability in hypertensive and normotensive subjecs[J].Turk Kardiyol Dern Ars,2015,43(1):18-24.DOI:10.5543/tkda.2015.10594. [46]KARAG?Z A,VURAL A,GüNAYD N Z Y,et al.The role of neutrophil to lymphocyte ratio as a predictor of diastolic dysfunction in hypertensive patients[J].Eur Rev Med Pharmacol Sci,2015,19(3):433-440. [47]SUN X N,LUO L M,ZHAO X Q,et al.The neutrophil-to-lymphocyte ratio on admission is a good predictor for all-cause mortality in hypertensive patients over 80 years of age[J].BMC Cardiovasc Disord,2017,17(1):167.DOI:10.1186/s12872-017-0595-1. [48]CHEN M C,CHANG J P,LIU W H,et al.Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation[J].Am J Cardiol,2008,102(7):861-865.DOI:10.1016/j.amjcard.2008.05.038. [49]BERKOVITCH A,YOUNIS A,GROSSMAN Y,et al.Relation of neutrophil to lymphocyte ratio to risk of incident atrial fibrillation[J].Am J Cardiol,2019,123(3):396-401.DOI:10.1016/j.amjcard.2018.10.036. [50]WEYMANN A,ALI HASAN AL SAEGH S,SABASHNIKOV A,et al.Prediction of new-onset and recurrent atrial fibrillation by complete blood count tests:a comprehensive systematic review with meta-analysis[J].Med Sci Monit Basic Res,2017,23:179-222.DOI:10.12659/MSMBR.903320. [51]LIU T,LI G P.Is atrial fibrillation an inflammatory disease?[J].Med Hypotheses,2005,64(6):1237-1238.DOI:10.1016/j.mehy.2005.01.004. [52]BOOS C J,ANDERSON R A,LIP G Y H.Is atrial fibrillation an inflammatory disorder?[J].Eur Heart J,2006,27(2):136-149.DOI:10.1093/eurheartj/ehi645. [53]王涛,王振,赵烨,等.中性粒细胞与淋巴细胞比值对心房颤动射频消融术后复发的预测价值[J].中国循证心血管医学杂志,2019,11(3):367-370.DOI:10.3969/j.issn.1674-4055.2019.03.25. WANG T,WANG Z,ZHAO Y,et al.Predictive value of neutrophil-lymphocyte ratio in recurrence of atrial fibrillation after radiofrequency ablation[J].Chin J Evid - Based Cardiovasc Med,2019,11(3):367-370.DOI:10.3969/j.issn.1674-4055.2019.03.25. [54]YALCIN M,APARCI M,UZ O,et al.Neutrophil-lymphocyte ratio May predict left atrial thrombus in patients with nonvalvular atrial fibrillation[J].Clin Appl Thromb Hemost,2015,21(2):166-171.DOI:10.1177/1076029613503398. [55]AYDIN M,YILDIZ A,YUKSEL M,et al.Assessment of the neutrophil/lymphocyte ratio in patients with supraventricular tachycardia[J].Anatol J Cardiol,2016,16(1):29-33.DOI:10.5152/akd.2015.5927. [56]YILDIZ A,OYLUMLU M,YUKSEL M,et al.The association between the neutrophil-to-lymphocyte ratio and the presence of ventricular premature contractions in young adults[J].Clin Appl Thromb Hemost,2015,21(5):475-479.DOI:10.1177/1076029613509478. [57]AKBOGA M K,AKYEL A,SAHINARSLAN A,et al.Neutrophil-to-lymphocyte ratio is increased in patients with rheumatic mitral valve stenosis?[J].Anatol J Cardiol,2015,15(5):380-384.DOI:10.5152/akd.2014.5399. [58]BAYSAL E,BURAK C,CAY S,et al.The neutrophil to lymphocyte ratio is associated with severity of rheumatic mitral valve stenosis[J].J Blood Med,2015,6:151-156.DOI:10.2147/JBM.S82423. [59]CHO K I,CHO S H,HER A Y,et al.Prognostic utility of neutrophil-to-lymphocyte ratio on adverse clinical outcomes in patients with severe calcific aortic stenosis[J].PLoS One,2016,11(8):e0161530.DOI:10.1371/journal.pone.0161530. [60]KHALIL C,PHAM M,SAWANT A C,et al.Neutrophil-to-lymphocyte ratio predicts heart failure readmissions and outcomes in patients undergoing transcatheter aortic valve replacement[J].Indian Heart J,2018,70(Suppl 3):S313-318.DOI:10.1016/j.ihj.2018.08.002. |
[1] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[2] | XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan. Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity [J]. Chinese General Practice, 2025, 28(26): 3229-3239. |
[3] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[4] | PAN Yaojia, FU Fanglin, HAN Zheng, SUN Meng, GU Huaicong, WANG Weiqiang. Correlation of the Type of Obesity with the Cardiometabolic Multimorbidity: a Study in Male and Female Middle-aged Residents in Anhui Province [J]. Chinese General Practice, 2025, 28(18): 2285-2293. |
[5] | HAN Zheng, SUN Meng, FU Fanglin, PAN Yaojia, WANG Weiqiang. A Study on the Relationship between the Triglyceride-Glucose Index and Cardiometabolic Multimorbidity in Individuals Aged 50 and Above [J]. Chinese General Practice, 2025, 28(18): 2278-2284. |
[6] | ZHANG Bingqing, WANG Zhongkai, WU Changyong, SUN Huang, LI Ruijie, LIU Wenjie, LUO Yihua, ZHENG Lihui, PENG Yunzhu. Changes and Trend Prediction in the Global Burden of Congenital Heart Defects, 1990-2021 [J]. Chinese General Practice, 2025, 28(18): 2253-2261. |
[7] | AN Qinyu, WANG Yiying, ZHANG Xiaodan, ZHANG Tianlin, ZHAN Qingqing, ZHANG Fuyan, LIU Tao, WU Yanli. Prospective Cohort Study of the Impact of Socioeconomic Status and Healthy Lifestyle on Cardiovascular Disease [J]. Chinese General Practice, 2025, 28(16): 2017-2024. |
[8] | NIE Yuanyuan, FANG Da, XU Hao, YANG Donghui, BI Yan, GU Tianwei. Clinical Characteristics and Cardiovascular Disease Risk of Type 2 Diabetes Populations with Different Liver Fibrosis Risks [J]. Chinese General Practice, 2025, 28(15): 1847-1854. |
[9] | KONG Xiaoqian, WANG Jingyi, WANG Li, MAO Ting, XIA Wenjing, SHI Yan. The Real Experience of Elderly People in Rural Areas Who Witnessed Acute Cardiovascular and Cerebrovascular Events: a Qualitative Study [J]. Chinese General Practice, 2025, 28(11): 1342-1346. |
[10] | ZHENG Xiaomeng, ZHOU Xuan, SUN Yu, FAN Miao, JIN Yiyi, ZHU Suyan. Clinical Characteristics and Medication Patterns of Patients with Cardiometabolic Multimorbidity [J]. Chinese General Practice, 2025, 28(09): 1061-1064. |
[11] | WANG Yuan, XIAO Fei, ZHANG Yuxin, ZHOU Enhui, ZHONG Jianqin, HU Yuxin, HONG Feng. Relationship between Ethnic Minority Speciality Diets and Cardiovascular Disease: Based on the Cohort Study of Natural Populations Living in Ethnic Minority Aggregation Areas in the Southwest Region [J]. Chinese General Practice, 2025, 28(06): 688-696. |
[12] | LIU Mingbo, HE Xinye, YANG Xiaohong, WANG Zengwu. Interpretation of Report on Cardiovascular Health and Diseases in China 2023 [J]. Chinese General Practice, 2025, 28(01): 20-38. |
[13] | LI Jie, DING Hu. Latest Progress of Lipoprotein (a) in Cardiovascular Diseases [J]. Chinese General Practice, 2024, 27(36): 4505-4514. |
[14] | ZHANG Jun, LUO Wen, WANG Luya, YANG Ya, CHEN Yan. Exploration and Practice of the Construction of Outpatient Model for Blood Lipid Management in Comprehensive Hospitals [J]. Chinese General Practice, 2024, 27(36): 4527-4533. |
[15] | ZHOU Yiheng, YANG Ziyu, LYU Yao, LIU Lidi, SHEN Can, LIAO Xiaoyang, JIA Yu. Interpretation of the Use of Artificial Intelligence in Improving Outcomes in Heart Disease:a Scientific Statement from the American Heart Association [J]. Chinese General Practice, 2024, 27(35): 4353-4357. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||